- Previous Close
1.5600 - Open
1.5600 - Bid 1.4600 x 100
- Ask 1.5400 x 100
- Day's Range
1.4300 - 1.5700 - 52 Week Range
1.0000 - 4.2700 - Volume
111,753 - Avg. Volume
216,694 - Market Cap (intraday)
10.243M - Beta (5Y Monthly) 4.64
- PE Ratio (TTM)
12.58 - EPS (TTM)
0.1200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Intelligent Bio Solutions Inc., a medical technology company, developing rapid, non-invasive testing, and screening solutions. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse. It also operates biosensor platform for clinical chemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York. The company operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
ibs.incRecent News: INBS
View MorePerformance Overview: INBS
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INBS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INBS
View MoreValuation Measures
Market Cap
10.24M
Enterprise Value
8.63M
Trailing P/E
12.58
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.69
Price/Book (mrq)
2.35
Enterprise Value/Revenue
2.85
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-76.78%
Return on Equity (ttm)
-291.77%
Revenue (ttm)
3.03M
Net Income Avi to Common (ttm)
-10.7M
Diluted EPS (ttm)
0.1200
Balance Sheet and Cash Flow
Total Cash (mrq)
2.24M
Total Debt/Equity (mrq)
14.89%
Levered Free Cash Flow (ttm)
-6.07M